SCHEMBL25166247

SCHEMBL25166247

CC1CCOc2c1cc(N)c(F)c2Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25166346 0.84 — —
SCHEMBL25166127 0.73 ADRA2A (0.33) —
SCHEMBL31108011 0.73 ADRA2A (0.33) —
SCHEMBL25166172 0.70 MAPT (0.36) —
SCHEMBL22143867 0.69 PGR (0.33) —
SCHEMBL24593733 0.69 PGR (0.33) —
SCHEMBL25166010 0.69 PARP1 (0.42) —
SCHEMBL25166593 0.67 PARP1 (0.34) —
SCHEMBL29991822 0.67 NOS3 (0.34) —
SCHEMBL25166481 0.64 MEN1 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023064586-A1 NOVEL MODULATORS OF EHMT1 AND EHMT2 AND THERAPEUTIC USE THEREOF TANGO THERAPEUTICS, INC. (US) 2023-04-20 — — WO disclosed
Send feedback